Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group
Authors:
- W. KochaWKW. Kocha
- J. MarounJMJ. Maroun
- H. KenneckeHKH. Kennecke
- C. LawCLC. Law
- P. MetrakosPMP. Metrakos
- J.F. OuelletJOJ.F. Ouellet
- R. ReidRRR. Reid
- C. RowsellCRC. Rowsell
- A. ShahASA. Shah
- S. SinghSSS. Singh
- S. Van UumSUS. Van Uum
- R. WongRWR. Wong
Open Access
- 1 June 2010
- journal article
- Published by MDPI AG in Current Oncology
- Vol. 17 (3) , 49-64
Abstract
Well-differentiated neuroendocrine tumours (nets-previously called "carcinoid tumours") are relatively rare tumours originating from the diffuse neuroendocrine system; they are found most often in the bronchial or gastrointestinal systems. In Canada, gastroenterohepatic NETS represent less than 0.25% of oncology cases. Because of the relative rarity of these tumours, diagnostic and therapeutic approaches vary and are often based on individual physician experience. A number of European and North American groups have developed consensus guidelines for the diagnosis and management of well-differentiated gastroenterohepatic NETS, and in 2006, Canadian consensus guidelines were published by a Canadian expert group. The updated and expanded current Canadian guidelines are based on a consensus meeting held in Paris, France, in 2008 and are based on the most current literature.Keywords
This publication has 83 references indexed in Scilit:
- Carcinoid Heart DiseaseCirculation, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Metastatic Carcinoid Tumors: A Clinical ReviewThe Oncologist, 2005
- The Diagnosis and Medical Management of Advanced Neuroendocrine TumorsEndocrine Reviews, 2004
- Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal TumoursNeuroendocrinology, 2004
- Bildgebung bei neuroendokrinen Tumoren des PankreasDer Radiologe, 2003
- Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine TumorsThe Journal of Clinical Endocrinology & Metabolism, 2001
- An analysis of 8305 cases of carcinoid tumorsCancer, 2000
- Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart diseaseJACC, 1998
- Somatostatin Receptor Scintigraphy in Patients with Carcinoid TumorsWorld Journal of Surgery, 1996